Evidence map›Paper›PMID 31573541›Full record

ArticleIET nanobiotechnology2019

Reduced graphene oxide: osteogenic potential for bone tissue engineering.

Mohammad Hadi Norahan, Masoud Amroon, Ramin Ghahremanzadeh, Navid Rabiee, Nafiseh Baheiraei

Abstract read
In one paragraph

Article in IET nanobiotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Graphene in 3D Bioprinting.Journal of functional biomaterials · 2024
    Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Engineering Functional Graphenic Materials for Bone Repair.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mohammad Hadi NorahanFaculty of New Sciences and Technologies, Semnan University, Semnan, Iran.
Masoud AmroonDepartment of Biomedical Engineering, Yazd Branch, Islamic Azad University, Yazd, Iran.
Ramin GhahremanzadehNanobiotechnology Research Center, Avicenna research institute, ACECR, Tehran, Iran.
Navid RabieeDepartment of Chemistry, Shahid Beheshti University, Tehran, Iran.
Nafiseh BaheiraeiTissue Engineering and Applied Cell Sciences Division, Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. n.baheiraei@modares.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Collagen (Col) type I, as the major component of the bone extracellular matrix has been broadly studied for bone tissue engineering. However,inferior mechanical properties limit its usage for load bearing applications. In this research, freeze dried Col scaffolds are coated with graphene oxide (GO) through a covalent bond of the amine Col with the graphene carboxyl groups. The prepared scaffolds were then reduced using a chemical agent. Scanning electron microscopy exhibited a porous structure for the synthesized scaffolds with an approximate pore size of 100-220 ± 12 µm, which is in the suitable range for bone tissue engineering application. Reducing the GO coating improved the compressive modulus of the Col from 250 to 970 kPa. Apatite formation was also indicated by immersing the scaffolds in simulated body fluid after five days. The cytocompatibility of the scaffolds, using human bone marrow-derived mesenchymal stem cells, was confirmed with MTT analysis. Alkaline phosphatase assay revealed that reducing the Col-GO scaffolds can effectively activate the differentiation of hBM-MSCs into osteoblasts after 14 days, even without the addition of an osteogenic differentiation medium. The results of this study highlight that GO and its reduced form have considerable potential as bone substitutes for orthopaedic and dental applications.

Indexed as

Bone and BonesBone RegenerationBone SubstitutesCell DifferentiationCell ProliferationCells, CulturedCoated Materials, BiocompatibleGraphiteHumansMesenchymal Stem CellsOsteoblastsOsteogenesisOxidation-ReductionPorosityTissue EngineeringTissue ScaffoldsBone SubstitutesCoated Materials, Biocompatiblegraphene oxideGraphite

Identifiers

PMID31573541
PMCPMC8676151

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.